[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 CDER FIRST ACTION PERFORMANCE FOR RESUBMITTED EFFICACY SUPPLEMENTS
Data as of FY 2005 Close-Out Cohort

CDER

FISCAL YEAR TYPE NO. SUBMITTED PDUFA GOALS NUMBER OF FIRST ACTIONS WITHIN GOAL NUMBER OF FIRST ACTIONS OVERDUE
      AP AE NA WD TOTAL AP AE NA WD TOTAL
              NO. PERCENT         NO. PERCENT
FY 03 as of 10/31/04 Class 1 16 30% in  2 mos. 12 3 0 0 15 94%            
90% in  6 mos. (cum.) 12 3 1 0 16 100% 0 0 0 0 0 0%
Class 2 40 90% in  6 mos. 31 8 1 0 40 100% 0 0 0 0 0 0%
Total 56                          
FY 04 as of 8/31/06 Class 1 32 50% in  2 mos. 29 0 1 0 30 94%            
90% in  6 mos. (cum.) 30 1 1 0 32 100% 0 0 0 0 0 0%
Class 2 23 90% in  6 mos. 11 6 5 0 22 96% 1 0 0 0 1 4%
Total 55                          
FY 05 as of 10/31/06 Class 1 23 70% in  2 mos. 19 2 2 0 23 100%            
90% in  6 mos. (cum.) 19 2 2 0 23 100% 0 0 0 0 0 0%
Class 2 21 90% in  6 mos. 7 4 5 4 20 95% 1 0 0 0 1 5%
Total 44                          

* The Class 1 Resubmission 2-month goal and performance figures are a subset of the 6-month goal.  These resubmissions are only considered overdue when they exceed the applicable 6-month goal.

Abbreviations:

AP    Approved

AE    Approvable

NA    Not approvable

WD   Withdrawn     

Back to Top     Reports

Date created: November 14, 2006; Updated January 17, 2007

horizonal rule